Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025
Kenvue (NYSE: KVUE), the world's largest pure-play consumer health company, has scheduled its fourth quarter and full year 2024 financial results announcement for February 6, 2025, before market open. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss the results.
Investors can access the conference call by dialing 877-407-8835 (U.S.) or +1 201-689-8779 (international). A live webcast will be available at investors.kenvue.com, with a replay accessible after the event. Kenvue's portfolio includes well-known brands such as Aveeno, BAND-AID, Johnson's, Listerine, Neutrogena, and Tylenol.
Kenvue (NYSE: KVUE), la più grande società al mondo nel settore della salute dei consumatori, ha programmato l'annuncio dei risultati finanziari per il quarto trimestre e l'anno intero 2024 per il 6 febbraio 2025, prima dell'apertura dei mercati. L'azienda ospiterà una conferenza telefonica e una diretta web alle 8:00 ora orientale per discutere i risultati.
Gli investitori possono partecipare alla conferenza chiamando il numero 877-407-8835 (USA) o +1 201-689-8779 (internazionale). Sarà disponibile una diretta web su investors.kenvue.com, con una registrazione accessibile dopo l'evento. Il portafoglio di Kenvue include marchi noti come Aveeno, BAND-AID, Johnson's, Listerine, Neutrogena e Tylenol.
Kenvue (NYSE: KVUE), la mayor empresa de salud para el consumidor en el mundo, ha programado el anuncio de sus resultados financieros para el cuarto trimestre y el año completo 2024 para el 6 de febrero de 2025, antes de la apertura del mercado. La compañía llevará a cabo una conferencia telefónica y una transmisión web a las 8:00 a.m. hora del Este para discutir los resultados.
Los inversionistas pueden acceder a la conferencia llamando al 877-407-8835 (EE. UU.) o al +1 201-689-8779 (internacional). Una transmisión en vivo estará disponible en investors.kenvue.com, con una repetición accesible después del evento. El portafolio de Kenvue incluye marcas reconocidas como Aveeno, BAND-AID, Johnson's, Listerine, Neutrogena y Tylenol.
Kenvue (NYSE: KVUE), 세계에서 가장 큰 소비자 건강 기업은 2024년 4분기 및 연간 재무 결과 발표를 2025년 2월 6일, 시장 개장 전에 예정하고 있습니다. 이 회사는 결과를 논의하기 위해 동부 표준시 기준 오전 8시에 전화 회의 및 웹캐스트를 개최할 것입니다.
투자자들은 877-407-8835 (미국) 또는 +1 201-689-8779 (국제)로 전화하여 회의에 접속할 수 있습니다. investors.kenvue.com에서 실시간 웹캐스트가 제공되며, 이벤트 후 재생이 가능합니다. Kenvue의 포트폴리오에는 Aveeno, BAND-AID, Johnson's, Listerine, Neutrogena 및 Tylenol과 같은 잘 알려진 브랜드가 포함되어 있습니다.
Kenvue (NYSE: KVUE), la plus grande entreprise de santé grand public au monde, a prévu d'annoncer ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour le 6 février 2025, avant l'ouverture des marchés. La société tiendra une conférence téléphonique et un webinaire à 8h00, heure de l'Est, pour discuter des résultats.
Les investisseurs peuvent accéder à la conférence téléphonique en composant le 877-407-8835 (États-Unis) ou le +1 201-689-8779 (international). Un webinaire en direct sera disponible sur investors.kenvue.com, avec un rediffusion accessible après l'événement. Le portefeuille de Kenvue comprend des marques bien connues telles qu'Aveeno, BAND-AID, Johnson's, Listerine, Neutrogena et Tylenol.
Kenvue (NYSE: KVUE), das größte Unternehmen für Verbrauchergesundheit weltweit, hat die Bekanntgabe seiner finanziellen Ergebnisse für das vierte Quartal und das gesamte Jahr 2024 für den 6. Februar 2025, vor Markteröffnung, angesetzt. Das Unternehmen wird um 8:00 Uhr Eastern Time eine Telefonkonferenz und ein Webcast abhalten, um die Ergebnisse zu besprechen.
Investoren können auf die Telefonkonferenz zugreifen, indem sie 877-407-8835 (USA) oder +1 201-689-8779 (international) anrufen. Ein Live-Webcast wird unter investors.kenvue.com verfügbar sein, mit einer Wiederholung, die nach der Veranstaltung zugänglich ist. Das Portfolio von Kenvue umfasst bekannte Marken wie Aveeno, BAND-AID, Johnson's, Listerine, Neutrogena und Tylenol.
- None.
- None.
The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the
About Kenvue
Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250123211823/en/
Investor Relations:
Sofya Tsinis
Kenvue_IR@Kenvue.com
Media Relations:
Melissa Witt
Media@Kenvue.com
Source: Kenvue
FAQ
When will Kenvue (KVUE) release its Q4 and full year 2024 earnings?
How can investors join Kenvue's Q4 2024 earnings call?
What time is Kenvue's Q4 2024 earnings conference call?
Which major consumer health brands are owned by Kenvue (KVUE)?
